title: Dehydroepiandrosterone sulphate: diabolical hormone or epiphenomenon in aneurysmal subarachnoid hemorrhage?
abstract: Inflammation is purported to play an important role in the clinical course of subarachnoid hemorrhage. The current study by Höllig et al. entails using dehydroepiandrosterone sulfate, a hormone that inhibits key inflammatory pathways, as a predictor of functional outcome in these patients.
authors.affiliation: Division of Neurosciences Critical Care, Johns Hopkins University School of Medicine, 600 N Wolfe St, Phipps 455, Baltimore, MD, 21287, USA. santoshbmurthy@gmail.com.
authors.forename: Santosh B
authors.initials: SB
authors.lastname: Murthy
authors.affiliation: Division of Neurosciences Critical Care, Johns Hopkins University School of Medicine, 600 N Wolfe St, Phipps 455, Baltimore, MD, 21287, USA. nnaval1@jhmi.edu.
authors.forename: Neeraj S
authors.initials: NS
authors.lastname: Naval
mesh_terms: D019314:Dehydroepiandrosterone Sulfate / Q000627:therapeutic use*; D006801:Humans; D002532:Intracranial Aneurysm / Q000175:diagnosis / Q000188:drug therapy*; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D011379:Prognosis; D013345:Subarachnoid Hemorrhage / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D018696:Neuroprotective Agents; D019314:Dehydroepiandrosterone Sulfate